Bristol-Myers Squibb Company

BMY · CIK 0000014272

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$48.19B0.2%

FY2025

Net income (FY)

$7.05B178.8%

FY2025

Free cash flow (FY)

$12.85B7.9%

FY2025

Diluted EPS (FY)

$3.46178.5%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 3.1× since FY2007 · net margin 13.9% → 14.6%

MarginsNet marginFCF margin

FY2025: net 14.6% · free cash flow 26.7% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $14.16B operating cash − $1.31B capex = $12.85B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 43% (FY2008) → 38% (FY2025) · on assets 7.8%

Balance sheetLiabilitiesEquity

FY2025: $90.04B assets · $71.53B liabilities · $18.47B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue	11,489	12,222	12,269	11,201	11,892	12,201	11,865	10,966	11,226	11,337	11,218	11,887
Net income	2,677	2,201	1,310	2,456	1,211	1,680	(11,911)	1,928	2,073	2,262	1,606	1,421
Diluted EPS	1.31	1.08	0.64	1.20	0.60	0.83	(5.89)	0.93	0.99	1.07	0.75	0.66
Diluted shares	2,047	2,039	2,038	2,040	2,031	2,029	2,023	2,064	2,102	2,113	2,148	2,149
Operating cash flow	1,104	—	—	1,954	—	—	2,834	—	—	2,970	—	—
Capital expenditures	347	—	—	260	—	—	284	—	—	278	—	—
Free cash flow	757	—	—	1,694	—	—	2,550	—	—	2,692	—	—
Cash & equivalents	9,574	15,726	12,599	10,875	7,890	6,293	9,330	7,514	8,372	8,995	7,734	10,750
Total assets	86,476	96,889	94,676	92,427	93,670	94,646	99,031	91,263	93,489	94,281	98,196	100,357
Total liabilities	66,374	78,289	77,187	74,979	76,470	77,577	82,483	62,201	61,459	62,395	65,462	67,696
Shareholders' equity	20,068	18,552	17,435	17,389	17,142	17,015	16,490	28,998	31,973	31,824	32,671	32,600

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.